Global Genital Herpes Treatment Drug Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Genital Herpes Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genital Herpes Treatment Drug.
The Genital Herpes Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genital Herpes Treatment Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genital Herpes Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genital Herpes Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Genital Herpes Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genital Herpes Treatment Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genital Herpes Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Fresenius Kabi
- Avet Pharmaceuticals Inc.
- Carlsbad Tech
- Glenmark Pharmaceuticals Inc.
- Zydus Pharmaceuticals
- Mylan Pharmaceutcials Inc.
- Apotex Inc.
- Epi Health LLC
- AiCuris Anti-infective Cures GmbH
- Chimerix
- Admedus
- Sanofi Pasteur SA
- Maruho Co. Ltd.
- F.Hoffmann-La Roche Ltd.
- Novartis AG
- Merck & Co. Inc.
- GlaxoSmithKline Plc
- Acyclovir (Zovirax)
- Famciclovir (Famvir)
- Valacyclovir (Valtrex)
- Others
- Hospital
- Clinic
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genital Herpes Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genital Herpes Treatment Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Acyclovir (Zovirax)
1.2.3 Famciclovir (Famvir)
1.2.4 Valacyclovir (Valtrex)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genital Herpes Treatment Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Genital Herpes Treatment Drug Market Perspective (2018-2029)
2.2 Genital Herpes Treatment Drug Growth Trends by Region
2.2.1 Global Genital Herpes Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genital Herpes Treatment Drug Historic Market Size by Region (2018-2023)
2.2.3 Genital Herpes Treatment Drug Forecasted Market Size by Region (2024-2029)
2.3 Genital Herpes Treatment Drug Market Dynamics
2.3.1 Genital Herpes Treatment Drug Industry Trends
2.3.2 Genital Herpes Treatment Drug Market Drivers
2.3.3 Genital Herpes Treatment Drug Market Challenges
2.3.4 Genital Herpes Treatment Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Genital Herpes Treatment Drug Players by Revenue
3.1.1 Global Top Genital Herpes Treatment Drug Players by Revenue (2018-2023)
3.1.2 Global Genital Herpes Treatment Drug Revenue Market Share by Players (2018-2023)
3.2 Global Genital Herpes Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genital Herpes Treatment Drug Revenue
3.4 Global Genital Herpes Treatment Drug Market Concentration Ratio
3.4.1 Global Genital Herpes Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genital Herpes Treatment Drug Revenue in 2022
3.5 Genital Herpes Treatment Drug Key Players Head office and Area Served
3.6 Key Players Genital Herpes Treatment Drug Product Solution and Service
3.7 Date of Enter into Genital Herpes Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GENITAL HERPES TREATMENT DRUG BREAKDOWN DATA BY TYPE
4.1 Global Genital Herpes Treatment Drug Historic Market Size by Type (2018-2023)
4.2 Global Genital Herpes Treatment Drug Forecasted Market Size by Type (2024-2029)
5 GENITAL HERPES TREATMENT DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Genital Herpes Treatment Drug Historic Market Size by Application (2018-2023)
5.2 Global Genital Herpes Treatment Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Genital Herpes Treatment Drug Market Size (2018-2029)
6.2 North America Genital Herpes Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genital Herpes Treatment Drug Market Size by Country (2018-2023)
6.4 North America Genital Herpes Treatment Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Genital Herpes Treatment Drug Market Size (2018-2029)
7.2 Europe Genital Herpes Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genital Herpes Treatment Drug Market Size by Country (2018-2023)
7.4 Europe Genital Herpes Treatment Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Genital Herpes Treatment Drug Market Size (2018-2029)
8.2 Asia-Pacific Genital Herpes Treatment Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Genital Herpes Treatment Drug Market Size (2018-2029)
9.2 Latin America Genital Herpes Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genital Herpes Treatment Drug Market Size by Country (2018-2023)
9.4 Latin America Genital Herpes Treatment Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Genital Herpes Treatment Drug Market Size (2018-2029)
10.2 Middle East & Africa Genital Herpes Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Fresenius Kabi
11.1.1 Fresenius Kabi Company Detail
11.1.2 Fresenius Kabi Business Overview
11.1.3 Fresenius Kabi Genital Herpes Treatment Drug Introduction
11.1.4 Fresenius Kabi Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.1.5 Fresenius Kabi Recent Development
11.2 Avet Pharmaceuticals Inc.
11.2.1 Avet Pharmaceuticals Inc. Company Detail
11.2.2 Avet Pharmaceuticals Inc. Business Overview
11.2.3 Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Introduction
11.2.4 Avet Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.2.5 Avet Pharmaceuticals Inc. Recent Development
11.3 Carlsbad Tech
11.3.1 Carlsbad Tech Company Detail
11.3.2 Carlsbad Tech Business Overview
11.3.3 Carlsbad Tech Genital Herpes Treatment Drug Introduction
11.3.4 Carlsbad Tech Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.3.5 Carlsbad Tech Recent Development
11.4 Glenmark Pharmaceuticals Inc.
11.4.1 Glenmark Pharmaceuticals Inc. Company Detail
11.4.2 Glenmark Pharmaceuticals Inc. Business Overview
11.4.3 Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Introduction
11.4.4 Glenmark Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.4.5 Glenmark Pharmaceuticals Inc. Recent Development
11.5 Zydus Pharmaceuticals
11.5.1 Zydus Pharmaceuticals Company Detail
11.5.2 Zydus Pharmaceuticals Business Overview
11.5.3 Zydus Pharmaceuticals Genital Herpes Treatment Drug Introduction
11.5.4 Zydus Pharmaceuticals Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.5.5 Zydus Pharmaceuticals Recent Development
11.6 Mylan Pharmaceutcials Inc.
11.6.1 Mylan Pharmaceutcials Inc. Company Detail
11.6.2 Mylan Pharmaceutcials Inc. Business Overview
11.6.3 Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Introduction
11.6.4 Mylan Pharmaceutcials Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.6.5 Mylan Pharmaceutcials Inc. Recent Development
11.7 Apotex Inc.
11.7.1 Apotex Inc. Company Detail
11.7.2 Apotex Inc. Business Overview
11.7.3 Apotex Inc. Genital Herpes Treatment Drug Introduction
11.7.4 Apotex Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.7.5 Apotex Inc. Recent Development
11.8 Epi Health LLC
11.8.1 Epi Health LLC Company Detail
11.8.2 Epi Health LLC Business Overview
11.8.3 Epi Health LLC Genital Herpes Treatment Drug Introduction
11.8.4 Epi Health LLC Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.8.5 Epi Health LLC Recent Development
11.9 AiCuris Anti-infective Cures GmbH
11.9.1 AiCuris Anti-infective Cures GmbH Company Detail
11.9.2 AiCuris Anti-infective Cures GmbH Business Overview
11.9.3 AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Introduction
11.9.4 AiCuris Anti-infective Cures GmbH Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.9.5 AiCuris Anti-infective Cures GmbH Recent Development
11.10 Chimerix
11.10.1 Chimerix Company Detail
11.10.2 Chimerix Business Overview
11.10.3 Chimerix Genital Herpes Treatment Drug Introduction
11.10.4 Chimerix Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.10.5 Chimerix Recent Development
11.11 Admedus
11.11.1 Admedus Company Detail
11.11.2 Admedus Business Overview
11.11.3 Admedus Genital Herpes Treatment Drug Introduction
11.11.4 Admedus Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.11.5 Admedus Recent Development
11.12 Sanofi Pasteur SA
11.12.1 Sanofi Pasteur SA Company Detail
11.12.2 Sanofi Pasteur SA Business Overview
11.12.3 Sanofi Pasteur SA Genital Herpes Treatment Drug Introduction
11.12.4 Sanofi Pasteur SA Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.12.5 Sanofi Pasteur SA Recent Development
11.13 Maruho Co. Ltd.
11.13.1 Maruho Co. Ltd. Company Detail
11.13.2 Maruho Co. Ltd. Business Overview
11.13.3 Maruho Co. Ltd. Genital Herpes Treatment Drug Introduction
11.13.4 Maruho Co. Ltd. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.13.5 Maruho Co. Ltd. Recent Development
11.14 F.Hoffmann-La Roche Ltd.
11.14.1 F.Hoffmann-La Roche Ltd. Company Detail
11.14.2 F.Hoffmann-La Roche Ltd. Business Overview
11.14.3 F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Introduction
11.14.4 F.Hoffmann-La Roche Ltd. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.14.5 F.Hoffmann-La Roche Ltd. Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Detail
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Genital Herpes Treatment Drug Introduction
11.15.4 Novartis AG Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.15.5 Novartis AG Recent Development
11.16 Merck & Co. Inc.
11.16.1 Merck & Co. Inc. Company Detail
11.16.2 Merck & Co. Inc. Business Overview
11.16.3 Merck & Co. Inc. Genital Herpes Treatment Drug Introduction
11.16.4 Merck & Co. Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.16.5 Merck & Co. Inc. Recent Development
11.17 GlaxoSmithKline Plc
11.17.1 GlaxoSmithKline Plc Company Detail
11.17.2 GlaxoSmithKline Plc Business Overview
11.17.3 GlaxoSmithKline Plc Genital Herpes Treatment Drug Introduction
11.17.4 GlaxoSmithKline Plc Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.17.5 GlaxoSmithKline Plc Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genital Herpes Treatment Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Acyclovir (Zovirax)
1.2.3 Famciclovir (Famvir)
1.2.4 Valacyclovir (Valtrex)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genital Herpes Treatment Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Genital Herpes Treatment Drug Market Perspective (2018-2029)
2.2 Genital Herpes Treatment Drug Growth Trends by Region
2.2.1 Global Genital Herpes Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genital Herpes Treatment Drug Historic Market Size by Region (2018-2023)
2.2.3 Genital Herpes Treatment Drug Forecasted Market Size by Region (2024-2029)
2.3 Genital Herpes Treatment Drug Market Dynamics
2.3.1 Genital Herpes Treatment Drug Industry Trends
2.3.2 Genital Herpes Treatment Drug Market Drivers
2.3.3 Genital Herpes Treatment Drug Market Challenges
2.3.4 Genital Herpes Treatment Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Genital Herpes Treatment Drug Players by Revenue
3.1.1 Global Top Genital Herpes Treatment Drug Players by Revenue (2018-2023)
3.1.2 Global Genital Herpes Treatment Drug Revenue Market Share by Players (2018-2023)
3.2 Global Genital Herpes Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genital Herpes Treatment Drug Revenue
3.4 Global Genital Herpes Treatment Drug Market Concentration Ratio
3.4.1 Global Genital Herpes Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genital Herpes Treatment Drug Revenue in 2022
3.5 Genital Herpes Treatment Drug Key Players Head office and Area Served
3.6 Key Players Genital Herpes Treatment Drug Product Solution and Service
3.7 Date of Enter into Genital Herpes Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GENITAL HERPES TREATMENT DRUG BREAKDOWN DATA BY TYPE
4.1 Global Genital Herpes Treatment Drug Historic Market Size by Type (2018-2023)
4.2 Global Genital Herpes Treatment Drug Forecasted Market Size by Type (2024-2029)
5 GENITAL HERPES TREATMENT DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Genital Herpes Treatment Drug Historic Market Size by Application (2018-2023)
5.2 Global Genital Herpes Treatment Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Genital Herpes Treatment Drug Market Size (2018-2029)
6.2 North America Genital Herpes Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genital Herpes Treatment Drug Market Size by Country (2018-2023)
6.4 North America Genital Herpes Treatment Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Genital Herpes Treatment Drug Market Size (2018-2029)
7.2 Europe Genital Herpes Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genital Herpes Treatment Drug Market Size by Country (2018-2023)
7.4 Europe Genital Herpes Treatment Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Genital Herpes Treatment Drug Market Size (2018-2029)
8.2 Asia-Pacific Genital Herpes Treatment Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Genital Herpes Treatment Drug Market Size (2018-2029)
9.2 Latin America Genital Herpes Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genital Herpes Treatment Drug Market Size by Country (2018-2023)
9.4 Latin America Genital Herpes Treatment Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Genital Herpes Treatment Drug Market Size (2018-2029)
10.2 Middle East & Africa Genital Herpes Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Fresenius Kabi
11.1.1 Fresenius Kabi Company Detail
11.1.2 Fresenius Kabi Business Overview
11.1.3 Fresenius Kabi Genital Herpes Treatment Drug Introduction
11.1.4 Fresenius Kabi Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.1.5 Fresenius Kabi Recent Development
11.2 Avet Pharmaceuticals Inc.
11.2.1 Avet Pharmaceuticals Inc. Company Detail
11.2.2 Avet Pharmaceuticals Inc. Business Overview
11.2.3 Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Introduction
11.2.4 Avet Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.2.5 Avet Pharmaceuticals Inc. Recent Development
11.3 Carlsbad Tech
11.3.1 Carlsbad Tech Company Detail
11.3.2 Carlsbad Tech Business Overview
11.3.3 Carlsbad Tech Genital Herpes Treatment Drug Introduction
11.3.4 Carlsbad Tech Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.3.5 Carlsbad Tech Recent Development
11.4 Glenmark Pharmaceuticals Inc.
11.4.1 Glenmark Pharmaceuticals Inc. Company Detail
11.4.2 Glenmark Pharmaceuticals Inc. Business Overview
11.4.3 Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Introduction
11.4.4 Glenmark Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.4.5 Glenmark Pharmaceuticals Inc. Recent Development
11.5 Zydus Pharmaceuticals
11.5.1 Zydus Pharmaceuticals Company Detail
11.5.2 Zydus Pharmaceuticals Business Overview
11.5.3 Zydus Pharmaceuticals Genital Herpes Treatment Drug Introduction
11.5.4 Zydus Pharmaceuticals Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.5.5 Zydus Pharmaceuticals Recent Development
11.6 Mylan Pharmaceutcials Inc.
11.6.1 Mylan Pharmaceutcials Inc. Company Detail
11.6.2 Mylan Pharmaceutcials Inc. Business Overview
11.6.3 Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Introduction
11.6.4 Mylan Pharmaceutcials Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.6.5 Mylan Pharmaceutcials Inc. Recent Development
11.7 Apotex Inc.
11.7.1 Apotex Inc. Company Detail
11.7.2 Apotex Inc. Business Overview
11.7.3 Apotex Inc. Genital Herpes Treatment Drug Introduction
11.7.4 Apotex Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.7.5 Apotex Inc. Recent Development
11.8 Epi Health LLC
11.8.1 Epi Health LLC Company Detail
11.8.2 Epi Health LLC Business Overview
11.8.3 Epi Health LLC Genital Herpes Treatment Drug Introduction
11.8.4 Epi Health LLC Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.8.5 Epi Health LLC Recent Development
11.9 AiCuris Anti-infective Cures GmbH
11.9.1 AiCuris Anti-infective Cures GmbH Company Detail
11.9.2 AiCuris Anti-infective Cures GmbH Business Overview
11.9.3 AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Introduction
11.9.4 AiCuris Anti-infective Cures GmbH Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.9.5 AiCuris Anti-infective Cures GmbH Recent Development
11.10 Chimerix
11.10.1 Chimerix Company Detail
11.10.2 Chimerix Business Overview
11.10.3 Chimerix Genital Herpes Treatment Drug Introduction
11.10.4 Chimerix Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.10.5 Chimerix Recent Development
11.11 Admedus
11.11.1 Admedus Company Detail
11.11.2 Admedus Business Overview
11.11.3 Admedus Genital Herpes Treatment Drug Introduction
11.11.4 Admedus Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.11.5 Admedus Recent Development
11.12 Sanofi Pasteur SA
11.12.1 Sanofi Pasteur SA Company Detail
11.12.2 Sanofi Pasteur SA Business Overview
11.12.3 Sanofi Pasteur SA Genital Herpes Treatment Drug Introduction
11.12.4 Sanofi Pasteur SA Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.12.5 Sanofi Pasteur SA Recent Development
11.13 Maruho Co. Ltd.
11.13.1 Maruho Co. Ltd. Company Detail
11.13.2 Maruho Co. Ltd. Business Overview
11.13.3 Maruho Co. Ltd. Genital Herpes Treatment Drug Introduction
11.13.4 Maruho Co. Ltd. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.13.5 Maruho Co. Ltd. Recent Development
11.14 F.Hoffmann-La Roche Ltd.
11.14.1 F.Hoffmann-La Roche Ltd. Company Detail
11.14.2 F.Hoffmann-La Roche Ltd. Business Overview
11.14.3 F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Introduction
11.14.4 F.Hoffmann-La Roche Ltd. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.14.5 F.Hoffmann-La Roche Ltd. Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Detail
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Genital Herpes Treatment Drug Introduction
11.15.4 Novartis AG Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.15.5 Novartis AG Recent Development
11.16 Merck & Co. Inc.
11.16.1 Merck & Co. Inc. Company Detail
11.16.2 Merck & Co. Inc. Business Overview
11.16.3 Merck & Co. Inc. Genital Herpes Treatment Drug Introduction
11.16.4 Merck & Co. Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.16.5 Merck & Co. Inc. Recent Development
11.17 GlaxoSmithKline Plc
11.17.1 GlaxoSmithKline Plc Company Detail
11.17.2 GlaxoSmithKline Plc Business Overview
11.17.3 GlaxoSmithKline Plc Genital Herpes Treatment Drug Introduction
11.17.4 GlaxoSmithKline Plc Revenue in Genital Herpes Treatment Drug Business (2018-2023)
11.17.5 GlaxoSmithKline Plc Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Genital Herpes Treatment Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Acyclovir (Zovirax)
Table 3. Key Players of Famciclovir (Famvir)
Table 4. Key Players of Valacyclovir (Valtrex)
Table 5. Key Players of Others
Table 6. Global Genital Herpes Treatment Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Genital Herpes Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Genital Herpes Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Genital Herpes Treatment Drug Market Share by Region (2018-2023)
Table 10. Global Genital Herpes Treatment Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Genital Herpes Treatment Drug Market Share by Region (2024-2029)
Table 12. Genital Herpes Treatment Drug Market Trends
Table 13. Genital Herpes Treatment Drug Market Drivers
Table 14. Genital Herpes Treatment Drug Market Challenges
Table 15. Genital Herpes Treatment Drug Market Restraints
Table 16. Global Genital Herpes Treatment Drug Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Genital Herpes Treatment Drug Market Share by Players (2018-2023)
Table 18. Global Top Genital Herpes Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Treatment Drug as of 2022)
Table 19. Ranking of Global Top Genital Herpes Treatment Drug Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Genital Herpes Treatment Drug Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Genital Herpes Treatment Drug Product Solution and Service
Table 23. Date of Enter into Genital Herpes Treatment Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Genital Herpes Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Genital Herpes Treatment Drug Revenue Market Share by Type (2018-2023)
Table 27. Global Genital Herpes Treatment Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Genital Herpes Treatment Drug Revenue Market Share by Type (2024-2029)
Table 29. Global Genital Herpes Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Genital Herpes Treatment Drug Revenue Market Share by Application (2018-2023)
Table 31. Global Genital Herpes Treatment Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Genital Herpes Treatment Drug Revenue Market Share by Application (2024-2029)
Table 33. North America Genital Herpes Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Genital Herpes Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Genital Herpes Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Genital Herpes Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Genital Herpes Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Genital Herpes Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Genital Herpes Treatment Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Genital Herpes Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Genital Herpes Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Genital Herpes Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Genital Herpes Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 48. Fresenius Kabi Company Detail
Table 49. Fresenius Kabi Business Overview
Table 50. Fresenius Kabi Genital Herpes Treatment Drug Product
Table 51. Fresenius Kabi Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 52. Fresenius Kabi Recent Development
Table 53. Avet Pharmaceuticals Inc. Company Detail
Table 54. Avet Pharmaceuticals Inc. Business Overview
Table 55. Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Product
Table 56. Avet Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 57. Avet Pharmaceuticals Inc. Recent Development
Table 58. Carlsbad Tech Company Detail
Table 59. Carlsbad Tech Business Overview
Table 60. Carlsbad Tech Genital Herpes Treatment Drug Product
Table 61. Carlsbad Tech Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 62. Carlsbad Tech Recent Development
Table 63. Glenmark Pharmaceuticals Inc. Company Detail
Table 64. Glenmark Pharmaceuticals Inc. Business Overview
Table 65. Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Product
Table 66. Glenmark Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 67. Glenmark Pharmaceuticals Inc. Recent Development
Table 68. Zydus Pharmaceuticals Company Detail
Table 69. Zydus Pharmaceuticals Business Overview
Table 70. Zydus Pharmaceuticals Genital Herpes Treatment Drug Product
Table 71. Zydus Pharmaceuticals Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 72. Zydus Pharmaceuticals Recent Development
Table 73. Mylan Pharmaceutcials Inc. Company Detail
Table 74. Mylan Pharmaceutcials Inc. Business Overview
Table 75. Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Product
Table 76. Mylan Pharmaceutcials Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 77. Mylan Pharmaceutcials Inc. Recent Development
Table 78. Apotex Inc. Company Detail
Table 79. Apotex Inc. Business Overview
Table 80. Apotex Inc. Genital Herpes Treatment Drug Product
Table 81. Apotex Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 82. Apotex Inc. Recent Development
Table 83. Epi Health LLC Company Detail
Table 84. Epi Health LLC Business Overview
Table 85. Epi Health LLC Genital Herpes Treatment Drug Product
Table 86. Epi Health LLC Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 87. Epi Health LLC Recent Development
Table 88. AiCuris Anti-infective Cures GmbH Company Detail
Table 89. AiCuris Anti-infective Cures GmbH Business Overview
Table 90. AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Product
Table 91. AiCuris Anti-infective Cures GmbH Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 92. AiCuris Anti-infective Cures GmbH Recent Development
Table 93. Chimerix Company Detail
Table 94. Chimerix Business Overview
Table 95. Chimerix Genital Herpes Treatment Drug Product
Table 96. Chimerix Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 97. Chimerix Recent Development
Table 98. Admedus Company Detail
Table 99. Admedus Business Overview
Table 100. Admedus Genital Herpes Treatment Drug Product
Table 101. Admedus Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 102. Admedus Recent Development
Table 103. Sanofi Pasteur SA Company Detail
Table 104. Sanofi Pasteur SA Business Overview
Table 105. Sanofi Pasteur SA Genital Herpes Treatment Drug Product
Table 106. Sanofi Pasteur SA Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 107. Sanofi Pasteur SA Recent Development
Table 108. Maruho Co. Ltd. Company Detail
Table 109. Maruho Co. Ltd. Business Overview
Table 110. Maruho Co. Ltd. Genital Herpes Treatment Drug Product
Table 111. Maruho Co. Ltd. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 112. Maruho Co. Ltd. Recent Development
Table 113. F.Hoffmann-La Roche Ltd. Company Detail
Table 114. F.Hoffmann-La Roche Ltd. Business Overview
Table 115. F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Product
Table 116. F.Hoffmann-La Roche Ltd. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 117. F.Hoffmann-La Roche Ltd. Recent Development
Table 118. Novartis AG Company Detail
Table 119. Novartis AG Business Overview
Table 120. Novartis AG Genital Herpes Treatment Drug Product
Table 121. Novartis AG Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 122. Novartis AG Recent Development
Table 123. Merck & Co. Inc. Company Detail
Table 124. Merck & Co. Inc. Business Overview
Table 125. Merck & Co. Inc. Genital Herpes Treatment Drug Product
Table 126. Merck & Co. Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 127. Merck & Co. Inc. Recent Development
Table 128. GlaxoSmithKline Plc Company Detail
Table 129. GlaxoSmithKline Plc Business Overview
Table 130. GlaxoSmithKline Plc Genital Herpes Treatment Drug Product
Table 131. GlaxoSmithKline Plc Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 132. GlaxoSmithKline Plc Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 1. Global Genital Herpes Treatment Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Acyclovir (Zovirax)
Table 3. Key Players of Famciclovir (Famvir)
Table 4. Key Players of Valacyclovir (Valtrex)
Table 5. Key Players of Others
Table 6. Global Genital Herpes Treatment Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Genital Herpes Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Genital Herpes Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Genital Herpes Treatment Drug Market Share by Region (2018-2023)
Table 10. Global Genital Herpes Treatment Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Genital Herpes Treatment Drug Market Share by Region (2024-2029)
Table 12. Genital Herpes Treatment Drug Market Trends
Table 13. Genital Herpes Treatment Drug Market Drivers
Table 14. Genital Herpes Treatment Drug Market Challenges
Table 15. Genital Herpes Treatment Drug Market Restraints
Table 16. Global Genital Herpes Treatment Drug Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Genital Herpes Treatment Drug Market Share by Players (2018-2023)
Table 18. Global Top Genital Herpes Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Treatment Drug as of 2022)
Table 19. Ranking of Global Top Genital Herpes Treatment Drug Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Genital Herpes Treatment Drug Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Genital Herpes Treatment Drug Product Solution and Service
Table 23. Date of Enter into Genital Herpes Treatment Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Genital Herpes Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Genital Herpes Treatment Drug Revenue Market Share by Type (2018-2023)
Table 27. Global Genital Herpes Treatment Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Genital Herpes Treatment Drug Revenue Market Share by Type (2024-2029)
Table 29. Global Genital Herpes Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Genital Herpes Treatment Drug Revenue Market Share by Application (2018-2023)
Table 31. Global Genital Herpes Treatment Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Genital Herpes Treatment Drug Revenue Market Share by Application (2024-2029)
Table 33. North America Genital Herpes Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Genital Herpes Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Genital Herpes Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Genital Herpes Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Genital Herpes Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Genital Herpes Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Genital Herpes Treatment Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Genital Herpes Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Genital Herpes Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Genital Herpes Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Genital Herpes Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 48. Fresenius Kabi Company Detail
Table 49. Fresenius Kabi Business Overview
Table 50. Fresenius Kabi Genital Herpes Treatment Drug Product
Table 51. Fresenius Kabi Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 52. Fresenius Kabi Recent Development
Table 53. Avet Pharmaceuticals Inc. Company Detail
Table 54. Avet Pharmaceuticals Inc. Business Overview
Table 55. Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Product
Table 56. Avet Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 57. Avet Pharmaceuticals Inc. Recent Development
Table 58. Carlsbad Tech Company Detail
Table 59. Carlsbad Tech Business Overview
Table 60. Carlsbad Tech Genital Herpes Treatment Drug Product
Table 61. Carlsbad Tech Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 62. Carlsbad Tech Recent Development
Table 63. Glenmark Pharmaceuticals Inc. Company Detail
Table 64. Glenmark Pharmaceuticals Inc. Business Overview
Table 65. Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Product
Table 66. Glenmark Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 67. Glenmark Pharmaceuticals Inc. Recent Development
Table 68. Zydus Pharmaceuticals Company Detail
Table 69. Zydus Pharmaceuticals Business Overview
Table 70. Zydus Pharmaceuticals Genital Herpes Treatment Drug Product
Table 71. Zydus Pharmaceuticals Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 72. Zydus Pharmaceuticals Recent Development
Table 73. Mylan Pharmaceutcials Inc. Company Detail
Table 74. Mylan Pharmaceutcials Inc. Business Overview
Table 75. Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Product
Table 76. Mylan Pharmaceutcials Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 77. Mylan Pharmaceutcials Inc. Recent Development
Table 78. Apotex Inc. Company Detail
Table 79. Apotex Inc. Business Overview
Table 80. Apotex Inc. Genital Herpes Treatment Drug Product
Table 81. Apotex Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 82. Apotex Inc. Recent Development
Table 83. Epi Health LLC Company Detail
Table 84. Epi Health LLC Business Overview
Table 85. Epi Health LLC Genital Herpes Treatment Drug Product
Table 86. Epi Health LLC Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 87. Epi Health LLC Recent Development
Table 88. AiCuris Anti-infective Cures GmbH Company Detail
Table 89. AiCuris Anti-infective Cures GmbH Business Overview
Table 90. AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Product
Table 91. AiCuris Anti-infective Cures GmbH Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 92. AiCuris Anti-infective Cures GmbH Recent Development
Table 93. Chimerix Company Detail
Table 94. Chimerix Business Overview
Table 95. Chimerix Genital Herpes Treatment Drug Product
Table 96. Chimerix Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 97. Chimerix Recent Development
Table 98. Admedus Company Detail
Table 99. Admedus Business Overview
Table 100. Admedus Genital Herpes Treatment Drug Product
Table 101. Admedus Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 102. Admedus Recent Development
Table 103. Sanofi Pasteur SA Company Detail
Table 104. Sanofi Pasteur SA Business Overview
Table 105. Sanofi Pasteur SA Genital Herpes Treatment Drug Product
Table 106. Sanofi Pasteur SA Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 107. Sanofi Pasteur SA Recent Development
Table 108. Maruho Co. Ltd. Company Detail
Table 109. Maruho Co. Ltd. Business Overview
Table 110. Maruho Co. Ltd. Genital Herpes Treatment Drug Product
Table 111. Maruho Co. Ltd. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 112. Maruho Co. Ltd. Recent Development
Table 113. F.Hoffmann-La Roche Ltd. Company Detail
Table 114. F.Hoffmann-La Roche Ltd. Business Overview
Table 115. F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Product
Table 116. F.Hoffmann-La Roche Ltd. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 117. F.Hoffmann-La Roche Ltd. Recent Development
Table 118. Novartis AG Company Detail
Table 119. Novartis AG Business Overview
Table 120. Novartis AG Genital Herpes Treatment Drug Product
Table 121. Novartis AG Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 122. Novartis AG Recent Development
Table 123. Merck & Co. Inc. Company Detail
Table 124. Merck & Co. Inc. Business Overview
Table 125. Merck & Co. Inc. Genital Herpes Treatment Drug Product
Table 126. Merck & Co. Inc. Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 127. Merck & Co. Inc. Recent Development
Table 128. GlaxoSmithKline Plc Company Detail
Table 129. GlaxoSmithKline Plc Business Overview
Table 130. GlaxoSmithKline Plc Genital Herpes Treatment Drug Product
Table 131. GlaxoSmithKline Plc Revenue in Genital Herpes Treatment Drug Business (2018-2023) & (US$ Million)
Table 132. GlaxoSmithKline Plc Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Genital Herpes Treatment Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Genital Herpes Treatment Drug Market Share by Type: 2022 VS 2029
Figure 3. Acyclovir (Zovirax) Features
Figure 4. Famciclovir (Famvir) Features
Figure 5. Valacyclovir (Valtrex) Features
Figure 6. Others Features
Figure 7. Global Genital Herpes Treatment Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Genital Herpes Treatment Drug Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Genital Herpes Treatment Drug Report Years Considered
Figure 13. Global Genital Herpes Treatment Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Genital Herpes Treatment Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Genital Herpes Treatment Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Genital Herpes Treatment Drug Market Share by Players in 2022
Figure 17. Global Top Genital Herpes Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Treatment Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Genital Herpes Treatment Drug Revenue in 2022
Figure 19. North America Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Genital Herpes Treatment Drug Market Share by Country (2018-2029)
Figure 21. United States Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Genital Herpes Treatment Drug Market Share by Country (2018-2029)
Figure 25. Germany Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Genital Herpes Treatment Drug Market Share by Region (2018-2029)
Figure 33. China Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Genital Herpes Treatment Drug Market Share by Country (2018-2029)
Figure 41. Mexico Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Genital Herpes Treatment Drug Market Share by Country (2018-2029)
Figure 45. Turkey Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Fresenius Kabi Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 48. Avet Pharmaceuticals Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 49. Carlsbad Tech Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 50. Glenmark Pharmaceuticals Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 51. Zydus Pharmaceuticals Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 52. Mylan Pharmaceutcials Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 53. Apotex Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 54. Epi Health LLC Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 55. AiCuris Anti-infective Cures GmbH Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 56. Chimerix Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 57. Admedus Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 58. Sanofi Pasteur SA Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 59. Maruho Co. Ltd. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 60. F.Hoffmann-La Roche Ltd. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 61. Novartis AG Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 62. Merck & Co. Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 63. GlaxoSmithKline Plc Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Figure 1. Global Genital Herpes Treatment Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Genital Herpes Treatment Drug Market Share by Type: 2022 VS 2029
Figure 3. Acyclovir (Zovirax) Features
Figure 4. Famciclovir (Famvir) Features
Figure 5. Valacyclovir (Valtrex) Features
Figure 6. Others Features
Figure 7. Global Genital Herpes Treatment Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Genital Herpes Treatment Drug Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Genital Herpes Treatment Drug Report Years Considered
Figure 13. Global Genital Herpes Treatment Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Genital Herpes Treatment Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Genital Herpes Treatment Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Genital Herpes Treatment Drug Market Share by Players in 2022
Figure 17. Global Top Genital Herpes Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Treatment Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Genital Herpes Treatment Drug Revenue in 2022
Figure 19. North America Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Genital Herpes Treatment Drug Market Share by Country (2018-2029)
Figure 21. United States Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Genital Herpes Treatment Drug Market Share by Country (2018-2029)
Figure 25. Germany Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Genital Herpes Treatment Drug Market Share by Region (2018-2029)
Figure 33. China Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Genital Herpes Treatment Drug Market Share by Country (2018-2029)
Figure 41. Mexico Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Genital Herpes Treatment Drug Market Share by Country (2018-2029)
Figure 45. Turkey Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Genital Herpes Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Fresenius Kabi Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 48. Avet Pharmaceuticals Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 49. Carlsbad Tech Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 50. Glenmark Pharmaceuticals Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 51. Zydus Pharmaceuticals Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 52. Mylan Pharmaceutcials Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 53. Apotex Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 54. Epi Health LLC Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 55. AiCuris Anti-infective Cures GmbH Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 56. Chimerix Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 57. Admedus Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 58. Sanofi Pasteur SA Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 59. Maruho Co. Ltd. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 60. F.Hoffmann-La Roche Ltd. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 61. Novartis AG Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 62. Merck & Co. Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 63. GlaxoSmithKline Plc Revenue Growth Rate in Genital Herpes Treatment Drug Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
